Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0039 | 0.0459 | 0.2243 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0085 | 0.1407 | 0.511 |
Brugia malayi | polk-prov protein | 0.0026 | 0.0185 | 0.0185 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0085 | 0.1407 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0039 | 0.0442 | 0.1348 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.1022 | 0.7209 |
Giardia lamblia | DINP protein human, muc B family | 0.0085 | 0.1407 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0085 | 0.1407 | 0.4415 |
Schistosoma mansoni | ferritin | 0.0019 | 0.0029 | 0.0043 |
Loa Loa (eye worm) | glutathione reductase | 0.0039 | 0.0459 | 0.0442 |
Trypanosoma brucei | unspecified product | 0.0058 | 0.0857 | 0.281 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.0141 | 0.0482 |
Mycobacterium ulcerans | hypothetical protein | 0.0026 | 0.0185 | 0.1132 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0066 | 0.1022 | 0.3192 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0039 | 0.0459 | 0.3121 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0039 | 0.0459 | 0.1402 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0039 | 0.0459 | 0.1402 |
Leishmania major | DNA polymerase eta, putative | 0.0082 | 0.1354 | 0.489 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0053 | 0.0749 | 0.0733 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.0019 | 0.0029 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0039 | 0.0459 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.004 | 0.047 | 0.1438 |
Loa Loa (eye worm) | hypothetical protein | 0.014 | 0.2577 | 0.2564 |
Schistosoma mansoni | apoferritin-2 | 0.0019 | 0.0029 | 0.0043 |
Echinococcus granulosus | expressed protein | 0.0019 | 0.0029 | 0.0035 |
Trypanosoma brucei | trypanothione reductase | 0.0039 | 0.0459 | 0.1147 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0085 | 0.1407 | 0.5429 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0024 | 0.0141 | 0.0392 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0039 | 0.0459 | 0.0442 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0085 | 0.1407 | 0.1392 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0082 | 0.1354 | 0.489 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0039 | 0.0459 | 0.1402 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0058 | 0.0857 | 0.281 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0066 | 0.1022 | 0.5856 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.1223 | 0.1208 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.014 | 0.2577 | 0.2577 |
Brugia malayi | Muscleblind-like protein | 0.0168 | 0.3165 | 0.3165 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.055 | 0.0533 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.014 | 0.2577 | 1 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0201 | 0.0201 |
Treponema pallidum | bacterioferrin (TpF1) | 0.0019 | 0.0029 | 0.5 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.009 | 0.1515 | 0.8763 |
Trypanosoma brucei | unspecified product | 0.0058 | 0.0857 | 0.281 |
Plasmodium falciparum | thioredoxin reductase | 0.0039 | 0.0459 | 1 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0039 | 0.0459 | 0.1146 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0066 | 0.1022 | 0.3192 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.014 | 0.2577 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0085 | 0.1407 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0085 | 0.1407 | 0.511 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.1022 | 0.7209 |
Mycobacterium tuberculosis | Probable reductase | 0.009 | 0.1515 | 0.8763 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.009 | 0.1515 | 0.8763 |
Leishmania major | trypanothione reductase | 0.0039 | 0.0459 | 0.1147 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Schistosoma mansoni | ferritin light chain | 0.0019 | 0.0029 | 0.0043 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0039 | 0.0442 | 0.1348 |
Schistosoma mansoni | DNA polymerase eta | 0.014 | 0.2577 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.0201 | 0.0587 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0085 | 0.1407 | 0.511 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.0098 | 0.0081 |
Brugia malayi | Bromodomain containing protein | 0.008 | 0.1319 | 0.1319 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0024 | 0.0141 | 0.0392 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0496 | 0.048 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0064 | 0.0976 | 0.3044 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.01 | 0.1725 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.009 | 0.1515 | 0.8763 |
Echinococcus multilocularis | muscleblind protein | 0.0168 | 0.3165 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Brugia malayi | Bromodomain containing protein | 0.0041 | 0.0495 | 0.0495 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.0074 | 0.018 |
Echinococcus multilocularis | ferritin | 0.0019 | 0.0029 | 0.0035 |
Loa Loa (eye worm) | hypothetical protein | 0.0168 | 0.3165 | 0.3153 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0085 | 0.1407 | 0.8123 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0185 | 0.0167 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0039 | 0.0459 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0085 | 0.1407 | 0.511 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0039 | 0.0459 | 0.1724 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0039 | 0.0459 | 0.1146 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0201 | 0.0067 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.01 | 0.1725 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0085 | 0.1407 | 1 |
Brugia malayi | glutathione reductase | 0.0039 | 0.0459 | 0.0459 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0495 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0039 | 0.0459 | 0.2537 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.009 | 0.1515 | 0.8763 |
Plasmodium falciparum | glutathione reductase | 0.0039 | 0.0459 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0039 | 0.0459 | 0.1147 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.0201 | 0.0138 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Schistosoma mansoni | ferritin | 0.0019 | 0.0029 | 0.0043 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0085 | 0.1407 | 0.1407 |
Brugia malayi | Thioredoxin reductase | 0.0039 | 0.0459 | 0.0459 |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.0074 | 0.0221 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0039 | 0.0459 | 0.0459 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0082 | 0.1354 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0085 | 0.1407 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.1022 | 0.3926 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.0201 | 0.0067 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0201 | 0.0183 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.0201 | 0.0067 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0039 | 0.0459 | 0.3121 |
Echinococcus multilocularis | dna polymerase kappa | 0.0085 | 0.1407 | 0.4415 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0066 | 0.1022 | 0.7161 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0592 | 0.0576 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0085 | 0.1407 | 0.5429 |
Toxoplasma gondii | thioredoxin reductase | 0.0039 | 0.0459 | 0.2346 |
Echinococcus granulosus | ferritin | 0.0019 | 0.0029 | 0.0035 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.01 | 0.1725 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Schistosoma mansoni | bromodomain containing protein | 0.0068 | 0.1056 | 0.4058 |
Schistosoma mansoni | ferritin light chain | 0.0019 | 0.0029 | 0.0043 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0066 | 0.1022 | 0.7209 |
Echinococcus granulosus | muscleblind protein | 0.0168 | 0.3165 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0201 | 0.0067 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0459 | 0.0442 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0039 | 0.0459 | 0.3121 |
Leishmania major | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0064 | 0.0976 | 0.3044 |
Trypanosoma brucei | unspecified product | 0.0085 | 0.1407 | 0.511 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.01 | 0.1725 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0168 | 0.3165 | 0.3153 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0039 | 0.0459 | 0.1724 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0019 | 0.0031 | 0.0014 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Leishmania major | DNA polymerase eta, putative | 0.014 | 0.2577 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0085 | 0.1407 | 0.4415 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0039 | 0.0459 | 0.1146 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0201 | 0.0587 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0098 | 0.0314 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0039 | 0.0459 | 0.1402 |
Brugia malayi | PHD-finger family protein | 0.0027 | 0.0194 | 0.0194 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0201 | 0.0587 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0085 | 0.1407 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0058 | 0.0857 | 0.281 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0058 | 0.0857 | 0.281 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0039 | 0.0459 | 0.1402 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.004 | 0.047 | 0.1438 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0039 | 0.0459 | 0.1146 |
Echinococcus granulosus | dna polymerase kappa | 0.0085 | 0.1407 | 0.4415 |
Schistosoma mansoni | ferritin | 0.0019 | 0.0029 | 0.0043 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.0074 | 0.018 |
Schistosoma mansoni | ferritin | 0.0019 | 0.0029 | 0.0043 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0039 | 0.0459 | 0.1402 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0066 | 0.1022 | 0.3926 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Echinococcus multilocularis | dna polymerase eta | 0.014 | 0.2577 | 0.8132 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.009 | 0.1515 | 0.8763 |
Schistosoma mansoni | apoferritin-2 | 0.0019 | 0.0029 | 0.0043 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.009 | 0.1515 | 0.8763 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0168 | 0.3165 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0066 | 0.1022 | 0.3502 |
Brugia malayi | Cytochrome P450 family protein | 0.0053 | 0.0749 | 0.0749 |
Schistosoma mansoni | DNA polymerase IV / kappa | 0.0026 | 0.0185 | 0.0653 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0085 | 0.1407 | 0.8123 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0085 | 0.1407 | 0.511 |
Echinococcus multilocularis | expressed protein | 0.0019 | 0.0029 | 0.0035 |
Echinococcus granulosus | dna polymerase eta | 0.014 | 0.2577 | 0.8132 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cmax (ADMET) | = 33640 nM | Cmax in C57BL/cAnNCrl mouse at 10 mg/kg, po | ChEMBL. | 20597484 |
F (ADMET) | = 24 % | Oral bioavailability in C57BL/cAnNCrl mouse at 10 mg/kg | ChEMBL. | 20597484 |
T1/2 (ADMET) | = 5.9 hr | Half life in C57BL/cAnNCrl mouse at 10 mg/kg, po | ChEMBL. | 20597484 |
Tmax (ADMET) | = 3 hr | Tmax in C57BL/cAnNCrl mouse at 10 mg/kg, po | ChEMBL. | 20597484 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.